CARsgen Therapeutics Holdings Balance Sheet Health
Financial Health criteria checks 5/6
CARsgen Therapeutics Holdings has a total shareholder equity of CN¥1.8B and total debt of CN¥2.5M, which brings its debt-to-equity ratio to 0.1%. Its total assets and total liabilities are CN¥2.3B and CN¥455.5M respectively.
Key information
0.1%
Debt to equity ratio
CN¥2.52m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥1.85b |
| Equity | CN¥1.80b |
| Total liabilities | CN¥455.51m |
| Total assets | CN¥2.26b |
Financial Position Analysis
Short Term Liabilities: 2171's short term assets (CN¥1.9B) exceed its short term liabilities (CN¥196.2M).
Long Term Liabilities: 2171's short term assets (CN¥1.9B) exceed its long term liabilities (CN¥259.3M).
Debt to Equity History and Analysis
Debt Level: 2171 has more cash than its total debt.
Reducing Debt: Insufficient data to determine if 2171's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 2171 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: 2171 has sufficient cash runway for 2.9 years if free cash flow continues to reduce at historical rates of 13.7% each year.